Protocol for study of financial incentives for smoking cessation in pregnancy (FISCP): Randomised, multicentre study

BMJ Open

Volumn 6, Issue 7, 2016, Pages

  Berlin, Noémi ^a   Goldzahl, Léontine ^b   Jusot, Florence ^b   Berlin, Ivan ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITÉ PARIS DAUPHINE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

financial incentives; pregnant smokers; smoking cessation

Indexed keywords

ADULT; AMENORRHEA; ARTICLE; BEHAVIORAL ECONOMICS; BIRTH WEIGHT; CONTROLLED STUDY; FEMALE; FINANCIAL MANAGEMENT; FRANCE; HEALTH ECONOMICS; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL SMOKING; MATERNITY WARD; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL; REWARD; SENSITIVITY ANALYSIS; SMOKING CESSATION; TOBACCO CONSUMPTION; ADOLESCENT; CLINICAL TRIAL; ECONOMICS; METHODOLOGY; MOTIVATION; PREGNANCY COMPLICATION; SMOKING; TOBACCO;

ADOLESCENT; ADULT; CIGARETTE SMOKING; FEMALE; FRANCE; HUMANS; MOTIVATION; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANT WOMEN; RESEARCH DESIGN; REWARD; SMOKING CESSATION; TOBACCO PRODUCTS;

EID: 84980335280     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-011669     Document Type: Article

References (85)

1. Jusot F, Tubeuf S, Trannoy A. Circumstances and efforts: how important is their correlation for the measurement of inequality of opportunity in health? Health Econ 2013;22:1470-95.
2. Etilé F, Jones AM. Schooling and smoking among the baby boomers-an evaluation of the impact of educational expansion in France. J Health Econ 2011;30:811-31.
3. Bur Y. Proposition pour une nouvelle politique de lutte contre le tabac. 2012. http://www.sante.gouv.fr/rapport-de-yves-burproposition-pour-une-nouvelle-politique-de-lutte-contre-le-tabac.htm
4. Jacquat D, Touraine J. Rapport d'information sur l'evaluation des politiques publiques de lutte contre le tabagisme. 2013. http://www.assemblee-nationale.fr/14/rap-info/i0764.asp
5. Cour des comptes. Rapport d'évaluation des politiques de lutte contre le tabagisme. http://societe-francaise-de-tabacologie.com/dl/CourComptes-tabagisme2012.pdf
6. Kopp P. Le coût social des drogues en France. OFDT Note 2015-04. http://www.ofdt.fr/BDD/publications/docs/eisxpkv9.pdf
7. Nilsson PM, Hofvendahl S, Hofvendahl E, et al. Smoking in pregnancy in relation to gender and adult mortality risk in offspring: the Helsingborg Birth Cohort Study. Scand J Public Health 2006;34:660-4.
8. Knopik VS, Maccani MA, Francazio S, et al. The epigenetics of maternal cigarette smoking during pregnancy and effects on child development. Dev Psychopathol 2012;24:1377-90.
9. The health consequences of smoking-50 years of progress: a report of the surgeon general, 2014. http://www.surgeongeneral.gov/library/reports/50-years-of-progress/ (accessed 9 Apr 2015).
10. Buka SL, Shenassa ED, Niaura R. Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: a 30-year prospective study. Am J Psychiatry 2003;160:1978-84.
11. Ekblad M, Gissler M, Lehtonen L, et al. Prenatal smoking exposure and the risk of psychiatric morbidity into young adulthood. Arch Gen Psychiatry 2010;67:841-9.
12. Burke H, Leonardi-Bee J, Hashim A, et al. Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics 2012;129:735-44.
13. Oken E, Levitan EB, Gillman MW. Maternal smoking during pregnancy and child overweight: systematic review and metaanalysis. Int J Obes 2008;32:201-10.
14. Berlin I. Retentissement postnatal du tabagisme pendant la grossesse. Collège National des Gynécologues et Obstetriciens Français. Mises à jour en Gynécologie Médicale. 2010:205-10.
15. Doherty SP, Grabowski J, Hoffman C, et al. Early life insult from cigarette smoke may be predictive of chronic diseases later in life. Biomarkers 2009;14 (Suppl 1):97-101.
16. Stavrou EP, Baker DF, Bishop JF. Maternal smoking during pregnancy and childhood cancer in New South Wales: a record linkage investigation. Cancer Causes Control 2009;20:1551-8.
17. Brooks DR, Mucci LA, Hatch EE, et al. Maternal smoking during pregnancy and risk of brain tumors in the offspring. A prospective study of 1.4 million Swedish births. Cancer Causes Control 2004;15:997-1005.
18. Mucci LA, Granath F, Cnattingius S. Maternal smoking and childhood leukemia and lymphoma risk among 1,440,542 Swedish children. Cancer Epidemiol Biomarkers Prev 2004;13:1528-33.
19. Ferreira J. Pregnancy, maternal tobacco smoking, and early age leukemia in Brazil. Front Oncol 2012;2:151.
20. Enquète national périnatal. http://www.sante.gouv.fr/IMG/pdf/Les-naissances-en-2010-et-leur-evolution-depuis-2003.pdf (accessed 5 Nov 2015).
21. Institut national de la statistique et des études économiques, Insee-Population-Statistiques d'état civil sur les naissances en 2010. http://www.insee.fr/fr/themes/document.asp?ref-id=sd20101 (accessed 1 Apr 2016).
22. Lelong N, Kaminski M, Saurel-Cubizolles MJ, et al. Postpartum return to smoking among usual smokers who quit during pregnancy. Eur J Public Health 2001;11:334-9.
23. Letourneau AR, Sonja B, Mazure CM, et al. Timing and predictors of postpartum return to smoking in a group of inner-city women: an exploratory pilot study. Birth 2007;34:245-52.
24. Lauria L, Lamberti A, Grandolfo M. Smoking behaviour before, during, and after pregnancy: the effect of breastfeeding. Scientific World Journal 2012;2012:154910.
25. Jones M, Lewis S, Parrott S, et al. Re-starting smoking in the postpartum period after receiving a smoking cessation intervention: a systematic review. Addiction 2016;111:981-90.
26. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012;(11): CD000146.
27. Traitements de Substituts Nicotiniques (TSN) et femmes enceintes-ANSM: Agence nationale de sécurité du médicament et des produits de santé. http://ansm.sante.fr/S-informer/Presse-Communiques-Points-presse/Traitements-de-Substituts-Nicotiniques-TSN-et-femmes-enceintes/%28language%29/fre-FR (accessed 9 Apr 2015).
28. National Institute for Health and Care Excellence. NICE. Smoking: stopping in pregnancy and after childbirth. http://www.nice.org.uk/guidance/PH26/chapter/1-Recommendations#recommendation-5-useof-nrt-and-other-pharmacologicalsupport (accessed 19 Feb 2016).
29. Treating Tobacco Use and Dependence: 2008 Update-treating-tobacco-use08.pdf. http://www.ahrq.gov/professionals/clinicians-providers/guidelinesrecommendations/tobacco/clinicians/update/treating-tobacco-use08.pdf (accessed 9 Apr 2015).
30. Wisborg K, Henriksen TB, Jespersen LB, et al. Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol. 2000;96:967-71.
31. Kapur B, Hackman R, Selby P, et al. Randomized, double-blind, placebo controlled trial of nicotine replacement therapy in pregnancy. Curr Ther Res Clin Exp 2001;62:274-8.
32. Hotham ED, Gilbert AL, Atkinson ER. A randomised-controlled pilot study using nicotine patches with pregnant women. Addict Behav 2006;31:641-8.
33. Pollak KI, Oncken CA, Lipkus IM, et al. Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. Am J Prev Med 2007;33:297-305.
34. Oncken C, Dornelas E, Greene J, et al. Nicotine gum for pregnant smokers: a randomized controlled trial. Obstet Gynecol 2008;112:859-67.
35. Coleman T, Chamberlain C, Cooper S, et al. Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and metaanalysis. Addiction 2011;106:52-61.
36. Coleman T, Chamberlain C, Davey M-A, et al. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2012;(9):CD010078.
37. Coleman T, Cooper S, Thornton JG, et al. A randomized trial of nicotine-replacement therapy patches in pregnancy. N Engl J Med 2012;366:808-18.
38. Berlin I, Grangé G, Jacob N, et al. Nicotine patches in pregnant smokers: randomised, placebo controlled, multicentre trial of efficacy. BMJ 2014;348:g1622.
39. Coleman T, Chamberlain C, Davey M-A, et al. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2015;(12):CD010078.
40. Chaloupka FJ, Warner KE. Chapter 29 The economics of smoking. Handb Heal Econ 2000;1:1539-627.
41. Cawley J, Ruhm CJ. The economics of risky health behaviors. Handb Heal Econ 2011;2:95-199.
42. Grossman M. On the concept of health capital and the demand for health. J Polit Econ 1972;80:223-55.
43. Becker GS, Murphy KM. Theory of rational addiction. J Polit Econ 1988;96:675-700.
44. Grignon M, Reddock J. The effect of interventions targeting tobacco consumption: a review of literature reviews. Quest. d'économie la santé 2012;182:1-8.
45. Godefroy R. Les taxes sur les cigarettes sont-elles régressives? Économie publique/Public Econ 2003;13:3-28.
46. Colman GJ, Remler DK. Vertical equity consequences of very high cigarette tax increases: If the poor are the ones smoking, how could cigarette tax increases be progressive? J Policy Anal Manag 2008;27:376-400.
47. Cahill K, Hartmann-Boyce J, Perera R. Incentives for smoking cessation. Cochrane Database Syst Rev 2015;(5):CD004307.
48. Higgins ST, Solomon LJ. Some recent developments on financial incentives for smoking cessation among pregnant and newly postpartum women. Curr Addict Rep 2016;3:9-18.
49. Lumley J, Chamberlain C, Dowswell T, et al. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2009;(3):CD001055.
50. Tappin D, Bauld L, Purves D, et al. Financial incentives for smoking cessation in pregnancy: randomised controlled trial. BMJ 2015;350:h134.
51. Gruber J, Koszegi B. Is addiction 'rational'? Theory and evidence. Q J Econ 2001;116:1261-303.
52. Khwaja A, Silverman D. Sloan Frank, Time preference, time discounting, and smoking decisions. J Health Econ 2007;26:927-49.
53. Jusot F, Khlat M. The role of time and risk preferences in smoking inequalities: a population-based study. Addict Behav 2013;38:2167-73.
54. Brown H, Adams J. The role of time preference in smoking cessation: a longitudinal analysis of data from the Household Income and Labour Dynamics of Australia survey, 2001-08. Addiction 2013;108:186-92.
55. Grignon M. An empirical investigation of heterogeneity in time preferences and smoking behaviors. J Socio Econ 2009;38:739-51.
56. Anderson LR, Mellor JM. Predicting health behaviors with an experimental measure of risk preference. J Health Econ 2008;27:1260-74.
57. Gwaltney CJ, Metrik J, Kahler CW, et al. Self-efficacy and smoking cessation: a meta-analysis. Psychol Addict Behav 2009;23:56-66.
58. Hamilton KR, Mitchell MR, Wing VC, et al. Choice impulsivity: definitions, measurement issues, and clinical implications. Personal Disord 2015;6:182-98.
59. Mitchell SH. Measures of impulsivity in cigarette smokers and nonsmokers. Psychopharmacology 1999;146:455-64.
60. Doran N, Spring B, McChargue D, et al. Impulsivity and smoking relapse. Nicotine Tob Res 2004;6:641-7.
61. McCrae RR, Costa PT. Validation of the five-factor model of personality across instruments and observers. J Pers Soc Psychol 1987;52:81-90.
62. Malouff JM, Thorsteinsson EB, Schutte NS. The five-factor model of personality and smoking: a meta-analysis. J Drug Educ 2006;36:47-58.
63. Terracciano A, Costa PT. Smoking and the five-factor model of personality. Addiction 2004;99:472-81.
64. Inhalateurs électroniques de nicotine. In Rapport de l'OMS (2014). http://apps.who.int/gb/fctc/PDF/cop6/FCTC-COP6-10-fr.pdf
65. ANAES, Agence nationale d'accréditation et d'évaluation en santé. Conférence de consensus. Grossesse et tabac. (2004). http://www.has-sante.fr/portail/upload/docs/application/pdf/Grossesse-tabac-long.pdf (accessed 3 Apr 2016).
66. INPES. Institut national de prévention et d'éducation pour la santé. Grossesse et arrêt du tabac: Accompagner par l'écoute et le dialogue-Les essentiels de l'Inpes-Essentiel-GrossesseArretTabac.pdf. http://www.inpes.sante.fr/30000/pdf/2014/Essentiel-GrossesseArretTabac.pdf (accessed 3 Apr 2016).
67. MacArthur C, Newton JR, Knox EG. Effect of anti-smoking health education on infant size at birth: a randomized controlled trial. Br J Obstet Gynaecol 1987;94:295-300.
68. Hebel JR, Fox NL, Sexton M. Dose-response of birth weight to various measures of maternal smoking during pregnancy. J Clin Epidemiol 1988;41:483-9.
69. Li CQ, Windsor RA, Perkins L, et al. The impact on infant birth weight and gestational age of cotinine-validated smoking reduction during pregnancy. JAMA 1993;269:1519-24.
70. Benjamin-Garner R, Stotts A. Impact of smoking exposure change on infant birth weight among a cohort of women in a prenatal smoking cessation study. Nicotine Tob Res 2013;15:685-92.
71. Fagerström, K. Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res 2012;14:75-8.
72. Berlin I, Singleton E. G, Heishman S. J. Validity of the 12-item French version of the Tobacco Craving Questionnaire in treatmentseeking smokers. Nicotine Tob Res 2010;12:500-7.
73. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 1986;43:289-94.
74. The University of Vermont. Vermont Center on Behavior and Health. https://www.uvm.edu/medicine/behaviorandhealth/?Page=minnws.html&SM=research-sub.html (accessed 3 Apr 2016).
75. Ewing J. A. Detecting alcoholism. The CAGE questionnaire. JAMA 1984;252:1905-7.
76. Dohmen TJ, Falk A, Heckmann JJ et al. Individual risk attitudes: measurement, determinants, and behavioral consequences. J Eur Econ Assoc 2011;9:522-50.
77. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol 1995;51:768-74.
78. Baylé FJ, Bourdel MC, Caci H et al. Structure factorielle de la traduction française de l'échelle d'impulsivité de Barratt (BIS-10)./Factor structure of the French translation of the Barratt Impulsivity Scale (BIS-10). Can J Psychiatry 2000;45:156-65.
79. Labs SM, Wurtele SK. Fetal Health Locus of Control scale: development and validation. J Consult Clin Psychol 1986;54:814-19.
80. Hukkanen J, Jacob P, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005;57:79-115.
81. Boffetta P, Hecht S, Gray N, et al. Smokeless tobacco and cancer. Lancet Oncol 2008;9:667-75.
82. Marclay F, Saugy M. Determination of nicotine and nicotine metabolites in urine by hydrophilic interaction chromatographytandem mass spectrometry: potential use of smokeless tobacco products by ice hockey players. J Chromatogr A 2010;1217:7528-38.
83. Marclay F, Grata E, Perrenoud L, et al. A one-year monitoring of nicotine use in sport: frontier between potential performance enhancement and addiction issues. Forensic Sci Int 2011;213:73-84.
84. Nott KH, Vedhara K. The measurement and significance of stressful life events in a cohort of homosexual HIV positive men. AIDS Care 1995;7:55-69.
85. Boyd KA, Briggs AH, Bauld L, et al. Are financial incentives cost effective to support smoking cessation during pregnancy? Addiction 2016;111:360-70.